Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

LSTALSTA
10 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in LISATA THERAPEUTICS INC

Yes. Citadel Advisors holds 15,541 shares of LSTA (Lisata Therapeutics), worth $52,839, as of its Q2 2026 13F filing. It reduced the position by 7,125 shares (-31.4%) from Q1 2026. Citadel Advisors has held LSTA since Q1 2026, across 2 quarterly 13F filings.

Current Value

$52,839

Current Shares

15,541

Total Value Change

+$27,735

Total Shares Change

+5,459

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
15,541
-31.4%
$52,8390.0%$3.40
0
2026-Q1
New
22,666
-
$113,5570.0%$5.01
34
2025-Q1
Exited
0
-100.0%
$00.0%$2.35
0
2024-Q4
New
23,273
-
$69,3540.0%$2.98
32
2024-Q1
Exited
0
-100.0%
$00.0%$3.12
0
2023-Q4
Decreased
14,131
-23.9%
$38,5780.0%$2.73
0
2023-Q3
Increased
18,582
+8.2%
$38,8360.0%$2.14
15
2023-Q2
New
17,178
-
$63,5590.0%$3.70
32
2023-Q1
Exited
0
-100.0%
$00.0%$3.25
0
2022-Q4
New
10,082
-
$25,1040.0%$2.53
29

Other major holders of LSTA: VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used